Kymera Therapeutics, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q3 2019 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Kymera Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q3 2019 to Q3 2023.
  • Kymera Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $100K.
  • Kymera Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2023 was $200K.
  • Kymera Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Kymera Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
  • Kymera Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2020 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $200K $100K +$100K Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $100K $100K +$100K Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-03
Q1 2023 $0 $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $0 $0 $0 Oct 1, 2022 Dec 31, 2022 10-K 2023-02-23
Q3 2022 $0 $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $0 $0 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $0 $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $0 $0 $0 Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 $0 $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $0 $0 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $0 $0 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-03
Q4 2020 $0 $0 Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 $0 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2019 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.